Research shows that dogs’ immune systems age in complex, non-linear ways that differ between males and females, with male dogs showing more age-related changes in immune markers than females. In a 2026 cross-sectional study of 80 Beagles, Gram Research analysis found that some white blood cell counts declined with age before rising again in geriatric dogs, while immune signaling molecules called cytokines showed distinct sex-specific patterns. When researchers tested three anti-aging interventions on younger dogs for 90 days, rapamycin produced the broadest changes to immune markers, though all findings remain exploratory.

Researchers studied 80 Beagles ranging from 1 to 11 years old to understand how their immune systems change with age, and whether this process differs between males and females. According to Gram Research analysis, the study found that dogs’ immune aging is complex and doesn’t follow a simple pattern. The researchers also tested three anti-aging approaches on younger dogs: a drug called rapamycin, another drug called canagliflozin, and calorie restriction. Rapamycin showed the strongest effects on immune markers, while the other approaches had more limited impacts. These findings could help scientists understand aging in both dogs and humans.

Key Statistics

A 2026 cross-sectional study of 80 laboratory Beagles found that canine immune aging is heterogeneous and non-linear, with some white blood cell counts declining with age before rising again in geriatric dogs.

In a 90-day intervention trial with 24 young Beagles, rapamycin was associated with the broadest cytokine response compared to canagliflozin and dietary restriction, according to research published in Biogerontology.

Male Beagles showed more age-related changes in serum cytokines than females across the lifespan, though the difference was not statistically significant after correction for multiple comparisons in this 80-dog cross-sectional study.

Canagliflozin showed narrower cytokine differences alongside descriptive body-weight reduction in young Beagles over 90 days, while dietary restriction reduced body weight without altering measured immune endpoints.

The Quick Take

  • What they studied: How dogs’ immune systems change as they get older, and whether males and females experience these changes differently. The researchers also tested whether three anti-aging treatments could slow or reverse these changes.
  • Who participated: 80 laboratory Beagles ranging in age from 1 to 11 years old. Additionally, 24 younger dogs participated in a 90-day trial testing anti-aging treatments.
  • Key finding: Dogs’ immune systems age in complex, non-linear ways that differ between males and females. Male dogs showed more age-related changes in immune markers than females, though the difference wasn’t statistically significant after accounting for multiple comparisons. Among the anti-aging treatments tested, rapamycin produced the broadest changes to immune markers.
  • What it means for you: This research is primarily important for scientists studying aging in dogs and potentially humans. Pet owners should know this is early-stage research, and the anti-aging treatments tested are not yet proven safe or effective for dogs. Always consult your veterinarian before considering any anti-aging interventions for your pet.

The Research Details

This study used a cross-sectional design, meaning researchers collected blood samples and health information from 80 Beagles of different ages at a single point in time, rather than following the same dogs over many years. By comparing dogs of different ages, the researchers could identify patterns in how immune systems change with age. The researchers measured two main things: the number of different types of white blood cells in the dogs’ blood, and the levels of signaling molecules called cytokines that help coordinate immune responses. They looked for differences between male and female dogs at different life stages. In the second part of the study, 24 younger dogs received one of three interventions for 90 days: rapamycin (a drug that affects cell growth), canagliflozin (a diabetes drug), or dietary restriction (eating fewer calories). The researchers then measured immune markers again to see if these treatments changed how the dogs’ immune systems functioned.

Understanding how immune systems age is crucial because a weakening immune system contributes to many age-related diseases. Dogs age much faster than humans, making them valuable models for studying aging processes. By identifying sex-specific patterns in immune aging, researchers can design better studies and potentially develop treatments that account for biological differences between males and females. This approach could eventually lead to therapies that slow aging in both dogs and humans.

This study has several strengths: it used a controlled laboratory setting with purebred dogs of known ages, which reduces confounding factors. However, there are important limitations. The intervention portion involved only 24 dogs divided into small groups, which limits the ability to draw firm conclusions. The researchers measured immune markers only at the end of the 90-day intervention period, not throughout, so they couldn’t track how changes occurred over time. The researchers themselves noted that the intervention findings are exploratory and hypothesis-generating, meaning they’re meant to guide future research rather than provide definitive answers.

What the Results Show

The study revealed that canine immune aging is heterogeneous, meaning it doesn’t affect all dogs the same way, and non-linear, meaning it doesn’t follow a simple pattern of steady decline. Some types of white blood cells decreased with age in younger and middle-aged dogs but then increased again in very old dogs. Serum cytokines, the signaling molecules that coordinate immune responses, showed distinct patterns that differed between males and females. Male dogs showed more age-related changes in cytokine levels than females, though this difference was not statistically significant after the researchers applied statistical corrections for multiple comparisons. The researchers found that immune aging in dogs involves complex, stage-specific changes rather than a simple decline throughout life.

Among the three anti-aging interventions tested, rapamycin produced the broadest changes to immune markers, suggesting it had the most substantial effect on the dogs’ immune systems. Canagliflozin showed narrower changes to immune markers but was associated with descriptive reductions in body weight. Dietary restriction reduced body weight in the dogs but did not produce measurable changes in the immune markers the researchers tested. These findings suggest that different interventions may work through different biological mechanisms, and that weight loss alone may not be sufficient to alter immune function in the short term.

This research builds on existing knowledge that immune systems change with age, a process called immunosenescence. Previous studies in humans and other animals have shown that aging affects both the number and function of immune cells. This study adds to that knowledge by documenting sex-specific patterns in dogs and by testing whether common anti-aging interventions can modify these patterns. The finding that rapamycin affects immune markers aligns with previous research suggesting this drug may have anti-aging properties, though the clinical significance of these changes remains unclear.

The study has several important limitations. First, the cross-sectional design means researchers compared different dogs at different ages rather than following the same dogs over time, which limits the ability to understand individual aging trajectories. Second, the intervention portion involved small group sizes (approximately 6 to 8 dogs per treatment group), which reduces statistical power and increases the likelihood of chance findings. Third, the researchers measured immune markers only at the end of the 90-day intervention, not at intermediate timepoints, so they couldn’t determine when or how changes occurred. Fourth, the study was conducted in laboratory Beagles under controlled conditions, which may not reflect how these interventions would work in pet dogs with varied genetics, diets, and lifestyles. Finally, the researchers did not measure clinical outcomes like disease risk or lifespan, so it’s unclear whether the observed immune changes translate to meaningful health benefits.

The Bottom Line

This research does not yet support any specific recommendations for pet owners or veterinarians. The findings are exploratory and designed to guide future research. Anyone considering anti-aging interventions for their dog should consult with a veterinarian. Rapamycin, canagliflozin, and dietary restriction all require medical supervision and are not approved for anti-aging use in dogs. For scientists and veterinary researchers, this study provides a foundation for larger, longer-term studies examining how sex influences immune aging in dogs and whether anti-aging interventions can modify this process.

This research is most relevant to gerontologists (aging researchers), veterinary immunologists, and scientists studying translational aging research. Pet owners may find the findings interesting but should not attempt to apply them without veterinary guidance. The study is not yet applicable to clinical practice in veterinary medicine. Researchers studying human aging may find the canine model useful for understanding sex-specific patterns in immune aging.

The intervention portion of this study lasted only 90 days, which is a short timeframe for evaluating anti-aging effects. Meaningful changes in immune function and health outcomes typically require longer observation periods. If future studies confirm these findings, it could take several years of additional research before any interventions might be considered for clinical use in dogs.

Frequently Asked Questions

Do male and female dogs age differently in their immune systems?

Research suggests male dogs show more age-related changes in immune markers than females, though the difference wasn’t statistically significant after statistical corrections. A 2026 study of 80 Beagles found sex-stratified patterns in immune aging, indicating biological differences between males and females.

Can rapamycin slow aging in dogs?

Rapamycin showed the broadest changes to immune markers in a 90-day trial with young dogs, but this is early-stage research. The study was small and exploratory, and rapamycin is not approved for anti-aging use in dogs. Consult your veterinarian before considering any anti-aging treatments.

Does calorie restriction help dogs’ immune systems age better?

In a 90-day study, dietary restriction reduced body weight in young dogs but did not produce measurable changes in immune markers tested. This suggests weight loss alone may not alter immune function in the short term, though longer studies are needed.

At what age do dogs’ immune systems start to decline?

This study found that canine immune aging is non-linear and heterogeneous, meaning it doesn’t follow a simple pattern. Some immune markers declined with age before rising again in geriatric dogs, suggesting immune aging involves complex, stage-specific changes rather than steady decline.

How can I support my aging dog’s immune system?

This research doesn’t yet support specific recommendations for pet owners. Maintain regular veterinary checkups, provide balanced nutrition, ensure appropriate exercise, and discuss any concerns about your dog’s health with your veterinarian. They can recommend evidence-based approaches tailored to your dog’s individual needs.

Want to Apply This Research?

  • For dog owners using a pet health app, track your dog’s age category (puppy, adult, senior) alongside any changes in energy levels, infection frequency, or recovery time from illness. Note the dog’s sex and any dietary changes. This creates a personal record that can be shared with your veterinarian during wellness visits.
  • If your veterinarian recommends dietary changes for your aging dog, use the app to log daily food intake and portions. Track your dog’s weight weekly and note any changes in activity level or appetite. This data helps your veterinarian assess whether dietary modifications are having the intended effects.
  • Create a long-term health profile in your app that records your dog’s immune-related health events: infections, recovery times, vaccination responses, and any age-related health changes. Compare these patterns across different life stages. Share this information with your veterinarian annually to monitor your dog’s aging trajectory and adjust care as needed.

This research is preliminary and exploratory in nature. The findings describe patterns in laboratory Beagles and do not yet support clinical recommendations for pet care. Rapamycin, canagliflozin, and dietary restriction are not approved for anti-aging use in dogs and should not be administered without veterinary supervision. Pet owners should consult with their veterinarian before making any changes to their dog’s diet, medications, or health regimen. This article is for informational purposes only and should not be considered medical advice for your pet.

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: Sex-stratified immune patterns across the canine lifespan and short-term responses to geroprotective interventions. , Biogerontology (2026). PubMed 42837017 | DOI
Topics
dog immune aging canine immunosenescence sex differences aging rapamycin dogs geriatric dogs pet health aging immune markers dogs anti-aging interventions